Placenta
Volume 29 , Pages 129-134 , October 2008

Inflammatory Reaction and Implantation: the New Entries PTX3 and D6

  • C. Garlanda

      Affiliations

    • Istituto Clinico Humanitas IRCCS, via Manzoni 56, I-20089, Rozzano, Milan, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 02 82245115; fax: +39 02 82245101.
    • ,
  • V. Maina

      Affiliations

    • Istituto Clinico Humanitas IRCCS, via Manzoni 56, I-20089, Rozzano, Milan, Italy
    • ,
  • Y. Martinez de la Torre

      Affiliations

    • Istituto Clinico Humanitas IRCCS, via Manzoni 56, I-20089, Rozzano, Milan, Italy
    • ,
  • M. Nebuloni

      Affiliations

    • Pathology Unit, Luigi Sacco Department of Clinical Sciences, University of Milan, Milan, Italy
    • ,
  • M. Locati

      Affiliations

    • Istituto Clinico Humanitas IRCCS, via Manzoni 56, I-20089, Rozzano, Milan, Italy
    • Institute of General Pathology, University of Milan, Milan, Italy

,Accepted 20 June 2008.

References 

  1. Salamonsen LA, Dimitriadis E, Jones RL, Nie G. Complex regulation of decidualization: a role for cytokines and proteases–a review. Placenta. 2003;24(Suppl. A):S76–S85
  2. Genbacev OD, Prakobphol A, Foulk RA, Krtolica AR, Ilic D, Singer MS, et al. Trophoblast l-selectin-mediated adhesion at the maternal–fetal interface. Science. 2003;299:405–408
  3. Red-Horse K, Zhou Y, Genbacev O, Prakobphol A, Foulk R, McMaster M, et al. Trophoblast differentiation during embryo implantation and formation of the maternal–fetal interface. J Clin Invest. 2004;114:744–754
  4. Leonard S, Murrant C, Tayade C, van den Heuvel M, Watering R, Croy BA. Mechanisms regulating immune cell contributions to spiral artery modification—facts and hypotheses—a review. Placenta. 2006;27(Suppl. A):S40–S46
  5. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592–1594
  6. Reese J, Das SK, Paria BC, Lim H, Song H, Matsumoto H, et al. Global gene expression analysis to identify molecular markers of uterine receptivity and embryo implantation. J Biol Chem. 2001;276:44137–44145
  7. Popovici RM, Betzler NK, Krause MS, Luo M, Jauckus J, Germeyer A, et al. Gene expression profiling of human endometrial–trophoblast interaction in a coculture model. Endocrinology. 2006;147:5662–5675
  8. Hess AP, Hamilton AE, Talbi S, Dosiou C, Nyegaard M, Nayak N, et al. Decidual stromal cell response to paracrine signals from the trophoblast: amplification of immune and angiogenic modulators. Biol Reprod. 2007;76:102–117
  9. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996;87:2095–2147
  10. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol. 2001;1:135–145
  11. O'Neill LA. Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal?. Trends Immunol. 2002;23:296–300
  12. Dimitriadis E, White CA, Jones RL, Salamonsen LA. Cytokines, chemokines and growth factors in endometrium related to implantation. Hum Reprod Update. 2005;11:613–630
  13. Lindhard A, Bentin-Ley U, Ravn V, Islin H, Hviid T, Rex S, et al. Biochemical evaluation of endometrial function at the time of implantation. Fertil Steril. 2002;78:221–233
  14. Rossi M, Sharkey AM, Vigano P, Fiore G, Furlong R, Florio P, et al. Identification of genes regulated by interleukin-1beta in human endometrial stromal cells. Reproduction. 2005;130:721–729
  15. Vigano P, Mangioni S, Pompei F, Chiodo I. Maternal-conceptus cross talk–a review. Placenta. 2003;24(Suppl. B):S56–S61
  16. Gonzalez RR, Devoto L, Campana A, Bischof P. Effects of leptin, interleukin-1alpha, interleukin-6, and transforming growth factor-beta on markers of trophoblast invasive phenotype: integrins and metalloproteinases. Endocrine. 2001;15:157–164
  17. Sanchez-Cuenca J, Martin JC, Pellicer A, Simon C. Cytokine pleiotropy and redundancy–gp130 cytokines in human implantation. Immunol Today. 1999;20:57–59
  18. Guzeloglu-Kayisli O, Basar M, Arici A. Basic aspects of implantation. Reprod Biomed Online. 2007;15:728–739
  19. Girardi G, Bulla R, Salmon JE, Tedesco F. The complement system in the pathophysiology of pregnancy. Mol Immunol. 2006;43:68–77
  20. Xu C, Mao D, Holers VM, Palanca B, Cheng AM, Molina H. A critical role for murine complement regulator Crry in fetomaternal tolerance. Science. 2000;287:498–501
  21. Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med. 2006;203:2165–2175
  22. Bottazzi B, Garlanda C, Salvatori G, Jeannin P, Manfredi A, Mantovani A. Pentraxins as a key component of innate immunity. Curr Opin Immunol. 2006;18:10–15
  23. Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol. 2005;23:337–366
  24. Matsushita M, Fujita T. Ficolins and the lectin complement pathway. Immunol Rev. 2001;180:78–85
  25. Bottazzi B, Vouret-Craviari V, Bastone A, De Gioia L, Matteucci C, Peri G, et al. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem. 1997;272:32817–32823
  26. Doni A, Michela M, Bottazzi B, Peri G, Valentino S, Polentarutti N, et al. Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL-10 and inhibition by IFN-gamma. J Leukoc Biol. 2006;79:797–802
  27. Jaillon S, Peri G, Delneste Y, Fremaux I, Doni A, Moalli F, et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med. 2007;204:793–804
  28. Varani S, Elvin JA, Yan C, DeMayo J, DeMayo FJ, Horton HF, et al. Knockout of pentraxin 3, a downstream target of growth differentiation factor-9, causes female subfertility. Mol. Endocrinol. 2002;16:1154–1167
  29. Salustri A, Garlanda C, Hirsch E, De Acetis M, Maccagno A, Bottazzi B, et al. PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization. Development. 2004;131:1577–1586
  30. Garlanda C, Hirsch E, Bozza S, Salustri A, De Acetis M, Nota R, et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature. 2002;420:182–186
  31. Rovere P, Peri G, Fazzini F, Bottazzi B, Doni A, Bondanza A, et al. The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. Blood. 2000;96:4300–4306
  32. Camozzi M, Zacchigna S, Rusnati M, Coltrini D, Ramirez-Correa G, Bottazzi B, et al. Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo. Arterioscler Thromb Vasc Biol. 2005;
  33. Zhang X, Jafari N, Barnes RB, Confino E, Milad M, Kazer RR. Studies of gene expression in human cumulus cells indicate pentraxin 3 as a possible marker for oocyte quality. Fertil Steril. 2005;83(Suppl. 1):1169–1179
  34. Scarchilli L, Camaioni A, Bottazzi B, Negri V, Doni A, Deban L, et al. PTX3 interacts with inter-{alpha}-trypsin inhibitor: implications for hyaluronan organization and cumulus oophorus expansion. J Biol Chem. 2007;282:30161–30170
  35. Paffoni A, Ragni G, Doni A, Somigliana E, Pasqualini F, Restelli L, et al. Follicular fluid levels of the long pentraxin PTX3. J Soc Gynecol Investig. 2006;13:226–231
  36. Tranguch S, Chakrabarty A, Guo Y, Wang H, Dey SK. Maternal pentraxin 3 deficiency compromises implantation in mice. Biol Reprod. 2007;77:425–432
  37. Popovici RM, Krause MS, Jauckus J, Germeyer A, Brum IS, Garlanda C, et al. The long pentraxin PTX3 in human endometrium: regulation by steroids and trophoblast products. Endocrinology. 2008;149:1136–1143
  38. Muller B, Peri G, Doni A, Torri V, Landmann R, Bottazzi B, et al. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit Care Med. 2001;29:1404–1407
  39. Latini R, Maggioni AP, Peri G, Gonzini L, Lucci D, Mocarelli P, et al. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation. 2004;110:2349–2354
  40. Fazzini F, Peri G, Doni A, Dell'Antonio G, Dal Cin E, Bozzolo E, et al. PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation. Arthritis Rheum. 2001;44:2841–2850
  41. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999;180:499–506
  42. Cetin I, Cozzi V, Pasqualini F, Nebuloni M, Garlanda C, Vago L, et al. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol. 2006;194:1347–1353
  43. Rovere-Querini P, Antonacci S, Dell'Antonio G, Angeli A, Almirante G, Cin ED, et al. Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia. Obstet Gynecol. 2006;108:148–155
  44. Sargent IL, Borzychowski AM, Redman CW. NK cells and human pregnancy–an inflammatory view. Trends Immunol. 2006;27:399–404
  45. Assi F, Fruscio R, Bonardi C, Ghidini A, Allavena P, Mantovani A, et al. Pentraxin 3 in plasma and vaginal fluid in women with preterm delivery. Bjog. 2007;114:143–147
  46. Doni A, Paffoni A, Nebuloni M, Ragni G, Pasqualini F, Valentino S, et al. The long pentraxin 3 is a soluble and cell-associated component of the human semen. Int J Androl. 2007;
  47. Salamonsen LA, Zhang J, Brasted M. Leukocyte networks and human endometrial remodelling. J Reprod Immunol. 2002;57:95–108
  48. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med. 2006;12:1065–1074
  49. Jones RL, Hannan NJ, Kaitu'u TJ, Zhang J, Salamonsen LA. Identification of chemokines important for leukocyte recruitment to the human endometrium at the times of embryo implantation and menstruation. J Clin Endocrinol Metab. 2004;89:6155–6167
  50. Carlino C, Stabile H, Morrone S, Bulla R, Soriani A, Agostinis C, et al. Recruitment of circulating NK cells through decidual tissues: a possible mechanism controlling NK cell accumulation in the uterus during early pregnancy. Blood. 2008;111:3108–3115
  51. Kitaya K, Yamaguchi T, Yasuo T, Okubo T, Honjo H. Post-ovulatory rise of endometrial CD16(−) natural killer cells: in situ proliferation of residual cells or selective recruitment from circulating peripheral blood?. J Reprod Immunol. 2007;76:45–53
  52. Malamitsi-Puchner A, Vrachnis N, Samoli E, Baka S, Iliodromiti Z, Puchner KP, et al. Possible early prediction of preterm birth by determination of novel proinflammatory factors in midtrimester amniotic fluid. Ann N Y Acad Sci. 2006;1092:440–449
  53. Mantovani A, Locati M, Vecchi A, Sozzani S, Allavena P. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol. 2001;22:328–336
  54. Mantovani A, Bonecchi R, Locati M. Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol. 2006;6:907–918
  55. Nibbs RJ, Wylie SM, Yang J, Landau NR, Graham GJ. Cloning and characterization of a novel promiscuous human beta-chemokine receptor D6. J Biol Chem. 1997;272:32078–32083
  56. Bonecchi R, Locati M, Galliera E, Vulcano M, Sironi M, Fra AM, et al. Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor. J Immunol. 2004;172:4972–4976
  57. Bonecchi R, Borroni EM, Anselmo A, Doni A, Savino B, Mirolo M, et al. Regulation of D6 chemokine scavenging activity by ligand and Rab11-dependent surface upregulation. Blood 2008 May 16 [Epub ahead of print].
  58. Martinez de la Torre Y, Locati M, Buracchi C, Dupor J, Cook DN, Bonecchi R, et al. Increased inflammation in mice deficient for the chemokine decoy receptor D6. Eur J Immunol. 2005;35:1342–1346
  59. Jamieson T, Cook DN, Nibbs RJ, Rot A, Nixon C, McLean P, et al. The chemokine receptor D6 limits the inflammatory response in vivo. Nat Immunol. 2005;6:403–411
  60. Nibbs RJ, Kriehuber E, Ponath PD, Parent D, Qin S, Campbell JD, et al. The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am J Pathol. 2001;158:867–877
  61. Martinez de la Torre Y, Buracchi C, Borroni EM, Dupor J, Bonecchi R, Nebuloni M, et al. Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6. Proc Natl Acad Sci U S A. 2007;104:2319–2324
  62. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002;346:752–763
  63. Wessels JM, Linton NF, Croy BA, Tayade C. A review of molecular contrasts between arresting and viable porcine attachment sites. Am J Reprod Immunol. 2007;58:470–480

PII: S0143-4004(08)00199-9

doi: 10.1016/j.placenta.2008.06.008

Placenta
Volume 29 , Pages 129-134 , October 2008

Article Tools

* Image Usage & Resolution